510(k) Report

510(k) · Cleared

Cleared

NMP22 Bladderchek Kit, NMP22 Control Kit

K021231510(k) TraditionalCleared Jul 30, 2002103-day reviewClass II21 CFR 866.6010

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Matritech, Inc. · MMW System, Test, Tumor Marker, Monitoring, Bladder

Cleared on Jul 30, 2002 after a 103-day review. The FDA summary names its predicate without a number.

Decided
Jul 30, 2002
Review
103 days
Class
Class II
Product code
MMW
Recalls
None
Predicates
0

The FDA summary names its predicate without a number.

FIG. 1 — Lineage of K021231Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MMW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MMW device

  1. #1 K203245 Bladder EpiCheck DNA extraction kit…score 5.3 · 1 generation · no Class I recall
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—BTA Stat
Named without a submission number
—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All MMW devices

MMW System, Test, Tumor Marker, Monitoring, Bladder: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · MMW

1in 2023

2023: 1
2007high 1 (2023) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MMW

Too few MMW 510(k)s in any year since 2007 to give a median.

Recalls per year · MMW

No recall names MMW since 2007.

Adverse event reports per year · MMW

1in 2013

2010: 12011: 12012: 32013: 1
2007high 3 (2012) · low 0 (2007)2025

MAUDE reports naming product code MMW, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—01
20110—01
20120—03
20130—01
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—00
20231—00
20240—00
20250—00
20260—0—

What is it indicated for?

The NMP22 BladderChek test is indicated for use as an aid in monitoring

bladder cancer patients, by professional and prescription home use, in

conjunction with standard diagnostic procedures.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K021231: NMP22 Bladderchek Kit, NMP22 Control Kit.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K021231

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Page last updated Nov 3, 2026